unlocking the power of cancer mechanics

From cell assays to bedside diagnostics, ARTIDIS delivers nanomechanical insights that predict metastatic potential and guide treatment decisions.

Research and development
applications

Multimodal
patient data

From single measurements to predictive biomarkers
Artidisnet transforms nanomechanical data into clinically meaningful insights by integrating mechanical profiles with histopathology, genomics, imaging, and patient metadata. Our secure cloud platform enables seamless data management, real-time collaboration, and advanced analytics.

Whether you are running a research study or making treatment decisions, Artidisnet empowers you to move confidently from measurement to action.

Biomechanical phenotyping: label-free, non-destructive

Our platform brings atomic force microscopy into routine, point of care use, profiling tissues within their native microenvironment quickly and reproducibly.
Artidis® Research Device
Nanomechanical insights, at your fingertips
Our automated, AI-assisted platform brings atomic force microscopy to everyday research with speed, reproducibility, and scalability.

Capabilities:
  • Subcellular resolution in minutes
  • Built-in cloud analytics
  • High-throughput assays without sacrificing sensitivity
  • Seamless scale from benchtop to clinical research
Learn More
ARTIDIS Research Device
Nanomechanical insights, at your fingertips
Our automated, AI-assisted platform brings atomic force microscopy...
Clinical samples
Turn fresh tissue into immediate, actionable insight
Physical properties of the tumor and its microenvironment, like stiffness and deformability, often signal disease progression earlier and more accurately than molecular markers might because they are indicators of the tumor’s current state. ARTIDIS enables rapid nanomechanical profiling of fresh clinical samples within the tumor microenvironment, embedded in existing care pathways. Tissue integrity is preserved for downstream testing.

Clinicians and researchers can:
  • Discover predictive biomarkers based on mechanical properties
  • Stratify patients by metastatic potential at point of care
  • Guide specific treatment decisions (platinum vs. taxanes, checkpoint inhibitor optimization)
  • Access high-resolution data from core biopsies, FNAs, resections
Unlike liquid biopsies that measure isolated cells, ARTIDIS captures the complete picture: cancer cells, surrounding matrix, immune landscape, and physical barriers.
Learn More
Clinical TISSUE samples
Turn fresh tissue into immediate, actionable insight
Explore mechanical biomarkers.
Research models
From cells to preclinical models
ARTIDIS reveals how biological systems physically respond to their environment—unlocking insights into adhesion, migration, differentiation, and drug response across multiple model systems.

Applications include:
  • Cell-Based Assays - Track early cellular changes before molecular markers shift; study adhesion and migration dynamics
  • Organoid & 3D Models - Detect therapeutic effects earlier by tracking biomechanical shifts; link mechanical phenotype with molecular outcomes
  • Hydrogels & Biomaterials - Tune mechanical cues for stem cell differentiation; validate materials for clinical translation
  • Preclinical Tissues - Detect biomechanical changes before visible treatment effects; monitor immune infiltration in real time
Get clear, actionable results while preserving sample integrity for downstream analysis.
Learn More
Research models
From cells to preclinical models
Unlock mechanical insights across multiple model systems.
Core lab services
Send us your samples
Get high-resolution biomechanical data tailored to your study goals.

  • Fast turnaround (EU and US)
  • Scientific team support
  • Flexible options for academic and industry labs
Cells, hydrogels, organoids, preclinical tissues, fresh clinical biopsies

Contact us before shipping to confirm logistics and protocols.
Send us your sample
Core lab services
Send us your samples
Get high-resolution biomechanical data tailored to your study goals.
ARTIDIS Research Device
Nanomechanical insights, at your fingertips
Our automated, AI-assisted platform brings atomic force microscopy...
ARTIDIS Research Device
Nanomechanical insights, at your fingertips
Our automated, AI-assisted platform brings atomic force microscopy to everyday research with speed, reproducibility, and scalability.

Capabilities:
  • Subcellular resolution in minutes
  • Built-in cloud analytics
  • High-throughput assays without sacrificing sensitivity
  • Seamless scale from benchtop to clinical research
Learn More
Clinical Tissue samples
Turn fresh tissue into immediate, actionable insight
Explore mechanical biomarkers.
Clinical samples
Turn fresh tissue into immediate, actionable insight
Physical properties of the tumor and its microenvironment, like stiffness and deformability, often signal disease progression earlier and more accurately than molecular markers might because they are indicators of the tumor’s current state. ARTIDIS enables rapid nanomechanical profiling of fresh clinical samples within the tumor microenvironment, embedded in existing care pathways. Tissue integrity is preserved for downstream testing.

Clinicians and researchers can:
  • Discover predictive biomarkers based on mechanical properties
  • Stratify patients by metastatic potential at point of care
  • Guide specific treatment decisions (platinum vs. taxanes, checkpoint inhibitor optimization)
  • Access high-resolution data from core biopsies, FNAs, resections
Unlike liquid biopsies that measure isolated cells, ARTIDIS captures the complete picture: cancer cells, surrounding matrix, immune landscape, and physical barriers.
Learn More
Research models
From cells to preclinical models
Unlock insights across multiple model systems.
Research models
From cells to preclinical models
ARTIDIS reveals how biological systems physically respond to their environment—unlocking insights into adhesion, migration, differentiation, and drug response across multiple model systems.Applications include:Our automated, AI-assisted platform brings atomic force microscopy to everyday research with speed, reproducibility, and scalability.

Applications include:
  • Cell-Based Assays - Track early cellular changes before molecular markers shift; study adhesion and migration dynamics
  • Organoid & 3D Models - Detect therapeutic effects earlier by tracking biomechanical shifts; link mechanical phenotype with molecular outcomes
  • Hydrogels & Biomaterials - Tune mechanical cues for stem cell differentiation; validate materials for clinical translation
  • Preclinical Tissues - Detect biomechanical changes before visible treatment effects; monitor immune infiltration in real time
Get clear, actionable results while preserving sample integrity for downstream analysis.
Learn More
Core lab services
Send us your samples
Get high-resolution biomechanical data tailored to...
Core lab services
Send us your samples
Get high-resolution biomechanical data tailored to your study goals.

  • Fast turnaround (EU and US)
  • Scientific team support
  • Flexible options for academic and industry labs
Cells, hydrogels, organoids, preclinical tissues, fresh clinical biopsies

Contact us before shipping to confirm logistics and protocols.
Learn More

Augmented cancer research

Harness physics-driven insights to transform therapy development

Add a biomechanical layer to your research. Identify novel biomarkers, understand treatment resistance, and improve model predictivity by measuring tumors in their complete microenvironment.

Partner with us

Unique approach to treatment optimization:

By measuring cancer mechanics within the tumor microenvironment and combining with molecular and imaging data, 



Artidis uncovers predictive biomarkers that refine treatment strategies and accelerate drug discovery.

For Academic Researchers:
Explore Collaborative Research Opportunities
Access our platform, join collaborative studies, and co-develop novel biomarkers with leading institutions.
Learn More
For Industry Partners:
Discuss Biomarker Stratification and Drug Development Programs
Partner with Artidis to stratify patient populations, optimize therapeutic development, and create companion diagnostics.
Learn More
our partners

Clinical applications

Transforming cancer care with predictive and prognostic biomarkers

Treatment optimization across the patient journey
Artidis offers a pan-cancer solution for developing diagnostic and predictive biomarkers by measuring physical properties of tumors and the tumor microenvironment. Integrating real-time nanomechanical data with clinical, histopathological, and molecular information uncovers actionable insights traditional approaches miss.

This enables:
  • Earlier detection through mechanical fingerprinting
  • Metastatic risk assessment by measuring cellular deformability
  • Predictive treatment guidance for optimal therapy selection
Results delivered within hours, seamlessly embedded in standard workflows.

Our oncology portfolio

Aid to Radiology
When combined with patient-specific clinical information, tissue phenotyping within the tumor microenvironment offers exploratory insights into tissue characteristics. This supports ongoing studies investigating differences between benign and malignant tissue.
NEO-Match®
Assessment of cancer cell deformability and tumor microenvironment (TME) prior to therapy – currently undergoing clinical validation in multiple tumor types.
Analyzes the physical properties of the tumor and its microenvironment, providing insights that complement genomics and histology.

NEO-Match® characterizes:

Clinical validation

Measured curves to date
11.6
million curves
30
thousand maps
Our clinical trials
Artidis  approach is tumor-agnostic, with ongoing validation across breast, lung, pancreas, liver, and sarcoma cancers, and others.

Flagship breast cancer tissue phenotyping has already been tested on 500+ patient study, now validating in global 2,000+ patient ANGEL study (NCT06085833).
Sarcoma
UMBRELLA
Learn more
Liver
UMBRELLA
Learn more
Bladder
UMBRELLA
Learn more
Pancreas
Clinical Studies
UMBRELLA
Learn more
Breast
Clinical Studies
BRIGHT-RAD
NCT05406232
UMBRELLA
Learn more
Lung
UMBRELLA
Learn more
This represents only a portion of ongoing clinical trials.

Get in touch

Whether you are advancing cancer care, researching new therapeutic pathways, or building novel diagnostics, Artidis provides the tools and insights you need.

Join the mechanobiology revolution

Whether you're advancing cancer care, researching new therapeutic pathways, or building novel diagnostics, Artidis provides the tools and insights you need.

Careers

Be part of our mission
Apply